Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma.


OBJECTIVE During dopaminergic agonist treatment for macroprolactinoma, tumour shrinkage can be accompanied by secondary deterioration of the visual field in rare instances. The aim of the present study was to evaluate the incidence of symptomatic or asymptomatic delayed visual loss associated with chiasmal herniation during long-term cabergoline treatment… (More)
DOI: 10.1111/j.1365-2265.2008.03364.x


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics